France Multiomics Market Size & Outlook, 2023-2030

The multiomics market in France is expected to reach a projected revenue of US$ 238.1 million by 2030. A compound annual growth rate of 13.3% is expected of France multiomics market from 2024 to 2030.
Revenue, 2023 (US$M)
$99.3
Forecast, 2030 (US$M)
$238.1
CAGR, 2024 - 2030
13.3%
Report Coverage
France

France multiomics market highlights

  • The France multiomics market generated a revenue of USD 99.3 million in 2023 and is expected to reach USD 238.1 million by 2030.
  • The France market is expected to grow at a CAGR of 13.3% from 2024 to 2030.
  • In terms of segment, product was the largest revenue generating product & service in 2023.
  • Services is the most lucrative product & service segment registering the fastest growth during the forecast period.


Multiomics market data book summary

Market revenue in 2023USD 99.3 million
Market revenue in 2030USD 238.1 million
Growth rate13.3% (CAGR from 2023 to 2030)
Largest segmentProduct
Fastest growing segmentServices
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationServices, Product
Key market players worldwideThermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Shimadzu Corp, Bruker Corp, Qiagen NV, Agilent Technologies Inc, BD, Revvity Inc, BGI Group


Other key industry trends

  • In terms of revenue, France accounted for 4.2% of the global multiomics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, UK multiomics market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 634.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Multiomics Market Companies

Name Profile # Employees HQ Website

France multiomics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to multiomics market will help companies and investors design strategic landscapes.


Product was the largest segment with a revenue share of 59.92% in 2023. Horizon Databook has segmented the France multiomics market based on services, product covering the revenue growth of each sub-segment from 2018 to 2030.


The market scenario of multiomics in France was marked by active engagement in research and innovation, with numerous academic institutions, biotechnology companies, and pharmaceutical companies embracing multiomics technologies for various applications, such as drug discovery, biomarker identification, and personalized medicine. 

For instance, in February 2020, Scipio Bioscience, a French startup, raised around USD 6.8 million (EUR 6 million) in a Series A round for the development of cost-effective single-cell RNA sequencing kits. 

These cost-effective tests have shown high potential in profiling cells for research and clinical diagnostics. Furthermore, as per this initiative, genome sequencing is expected to be completed by more than 10 ultra-high throughput services, among which, two are already launched in the market.

Reasons to subscribe to France multiomics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of France multiomics market databook

  • Our clientele includes a mix of multiomics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the France multiomics market , including forecasts for subscribers. This country databook contains high-level insights into France multiomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

France multiomics market size, by product & service, 2018-2030 (US$M)

France Multiomics Market Outlook Share, 2023 & 2030 (US$M)

France multiomics market size, by product & service, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more